BAY-1436032

Item number	Size	Manual	Delivery time	Price
TGM-TQ0042-1mg	1 mg	-	7 - 10 business days*	32.00€
TGM-TQ0042-5mg	5 mg	-	7 - 10 business days*	71.00€
TGM-TQ0042-1mL	1 ml	-	7 - 10 business days*	76.00€
TGM-TQ0042-10mg	10 mg	-	7 - 10 business days*	119.00€
TGM-TQ0042-25mg	25 mg	-	7 - 10 business days*	-
TGM-TQ0042-50mg	50 mg	-	7 - 10 business days*	-

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: BAY-1436032 is a novel, selective and orally available inhibitor of pan-mutant... more

Close menu

Product information "BAY-1436032"

Description: BAY-1436032 is a novel, selective and orally available inhibitor of pan-mutant isocitrate dehydrogenase 1 (IDH1). Target: Isocitrate Dehydrogenase (IDH), Dehydrogenase. Smiles: C[C@H]1C[C@H](CC(C)(C)C1)n1c(Nc2ccc(OC(F)(F)F)cc2)nc2cc(CCC(O)=O)ccc12. References: Chaturvedi A, et al. Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo. Leukemia. 2017 Oct,31(10):2020-2028.

Supplier:	TargetMol
Supplier-Nr:	TQ0042

Properties

Application:	Mutant IDH1 inhibitor
MW:	489.53 D
Formula:	C26H30F3N3O3

Database Information

CAS :	1803274-65-8\| Matching products
KEGG ID :	K00031 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "BAY-1436032"

Write a review